Verrica Pharmaceuticals Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €6.45M +47.7% -€65.32M +14.3% -1,012.1% +3.0 pp -€51.94M +59.4% -804.9% -0.59 pp
    €4.37M -43.3% -€57.14M +142.1% -1,307.5% -10 pp -€32.60M +108.3% -745.8% -5.4 pp
    €7.70M -24.7% -€23.61M -28.9% -306.4% +0.18 pp -€15.65M -31.3% -203.1% +0.19 pp
    €10.24M +∞% -€33.18M -14.5% -324.2% -3.2 pp -€22.77M -7.1% -222.5% -2.2 pp
    €0.00 +NaN% -€38.81M +62.8% N/A -€24.51M +7.5% N/A
    €0.00 +NaN% -€23.84M +35.4% N/A -€22.80M +56.3% N/A
    €0.00 +NaN% -€17.61M +363.1% N/A -€14.59M +273.1% N/A
    €0.00 +NaN% -€3.80M +133.1% N/A -€3.91M +184.5% N/A
    €0.00 -€1.63M N/A -€1.37M N/A

    Notifications